Newborn Screening for Inborn Errors of Metabolism by Next-Generation Sequencing Combined with Tandem Mass Spectrometry
Open Access
- 29 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 10 (2) , 28
Abstract
The aim of this study was to observe the outcomes of newborn screening (NBS) in a certain population by using next-generation sequencing (NGS) as a first-tier screening test combined with tandem mass spectrometry (MS/MS). We performed a multicenter study of 29,601 newborns from eight screening centers with NBS via NGS combined with MS/MS. A custom-designed panel targeting the coding region of the 142 genes of 128 inborn errors of metabolism (IEMs) was applied as a first-tier screening test, and expanded NBS using MS/MS was executed simultaneously. In total, 52 genes associated with the 38 IEMs screened by MS/MS were analyzed. The NBS performance of these two methods was analyzed and compared respectively. A total of 23 IEMs were diagnosed via NGS combined with MS/MS. The incidence of IEMs was approximately 1 in 1287. Within separate statistical analyses, the positive predictive value (PPV) for MS/MS was 5.29%, and the sensitivity was 91.3%. However, for genetic screening alone, the PPV for NGS was 70.83%, with 73.91% sensitivity. The three most common IEMs were methylmalonic academia (MMA), primary carnitine deficiency (PCD) and phenylketonuria (PKU). The five genes with the most common carrier frequencies were PAH (1:42), PRODH (1:51), MMACHC (1:52), SLC25A13 (1:55) and SLC22A5 (1:63). Our study showed that NBS combined with NGS and MS/MS improves the performance of screening methods, optimizes the process, and provides accurate diagnoses.Keywords
Funding Information
- Scientific Research Project Plan of the Shanghai Municipal Health Commission (202140346, 202201020618, 2020GG0119)
- Science and Technology Projects in Guangzhou (202140346, 202201020618, 2020GG0119)
- Application Technology Research and Development Project of the Inner Mongolia Autonomous Region (202140346, 202201020618, 2020GG0119)
- BGI Genomics (202140346, 202201020618, 2020GG0119)
This publication has 43 references indexed in Scilit:
- Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn ScreeningJAMA Network Open, 2023
- Incorporation of second‐tier tests and secondary biomarkers to improve positive predictive value (PPV) rate in newborn metabolic screening programJournal of Clinical Laboratory Analysis, 2022
- Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening expertsWorld Journal of Pediatrics, 2022
- The transitivity of the Hardy–Weinberg lawForensic Science International: Genetics, 2022
- Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature reviewEuropean Journal of Medical Genetics, 2019
- Clinical and molecular characteristics of carnitine-acylcarnitine translocase deficiency: Experience with six patients in Guangdong ChinaClinica Chimica Acta, 2019
- Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese populationClinica Chimica Acta, 2019
- Expanded newborn screening by mass spectrometry: New tests, future perspectivesMass Spectrometry Reviews, 2015
- Genotype–Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation UpdateJournal of Genetics and Genomics, 2015
- Newborn Screening for Inborn Errors of Metabolism in Mainland China: 30 Years of Experience2012